+1 704-993-8389
Advocacy & Awareness for Immune Disorders Association (AAIDA)
About Us
Mission and Vision
Executive Leadership Team
Our Directors & Team
Story About Us
AAIDA In The News
Advocacy Initiatives
Get Involved
Donate
Get In Touch
Sign Up For Updates
AAIDA Apparel
Immune Disorders
Educational Websites
Educational Articles By Subject
All Educational Articles (Alphabetically)
Autoimmune and Immunosuppressed
COVID-19 & Vaccines
Immune Dysregulation
Immune System Components
IVIG & SCIG
PANDAS
Primary Immunodeficiency (PI)
Federal Healthcare Policy Laws, News & Other Resources
Stories
Programs
Webinars
Events
Donate Now
Immune Dysregulation
What You Need to Know About Biosimilar Treatment Options, March 1, 2023
Probiotic Markedly Reduces S. Aureus Colonization In Phase 2 Trial, January 17, 2023
Emerging Strategies For Treating Autoimmune Disorders With Genetically Modified Treg Cells, January 1st, 2022
Biosimilar Product Information
Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator Conference, June 2021
How T Cells Sense Dangerous Invaders, June 17th, 2021
What are immunosuppressants?
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial, July 2021
What Is Sjögren’s Syndrome? Symptoms, Causes, Diagnosis, Treatment, and Prevention, January 28th, 2021
NIH Scientists Illuminate Role of Staph Toxins in Bacterial Sepsis, February 3rd, 2017
Loss of B Cells in Patients with Heterozygous Mutations in IKAROS, March 17th, 2016
X-linked primary immunodeficiency associated with hemizygous mutations in the moesin (MSN) gene, April 3rd, 2016